Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2Plasma cell 1

Conditions

Myelodysplastic Syndromes 112Leukemia, Myeloid, Acute 107Precursor Cell Lymphoblastic Leukemia-Lymphoma 96Leukemia, Lymphocytic, Chronic, B-Cell 81Hodgkin Disease 81Lymphoma, Non-Hodgkin 75Multiple Myeloma 68Leukemia 63Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Myeloproliferative Disorders 58Lymphoma, Mantle-Cell 56Lymphoma, Follicular 56Lymphoma 54Lymphoma, Large B-Cell, Diffuse 50Lymphoma, B-Cell, Marginal Zone 48Leukemia, Myelomonocytic, Chronic 44Leukemia, Myeloid, Chronic-Phase 44Burkitt Lymphoma 44Congenital Abnormalities 41Lymphoma, Large-Cell, Immunoblastic 38Leukemia, Myeloid, Accelerated Phase 37Primary Myelofibrosis 36Blast Crisis 32Neoplasms, Plasma Cell 31Anemia, Refractory, with Excess of Blasts 29Dendritic Cell Sarcoma, Interdigitating 28Leukemia, Biphenotypic, Acute 27Waldenstrom Macroglobulinemia 25Recurrence 25Lymphoma, T-Cell, Cutaneous 24

Interventions

fludarabine phosphate 3Whole-Body Irradiation 3Melphalan 3Cyclophosphamide 3Azacitidine 3fludarabine 2Mycophenolic Acid 2Imatinib Mesylate 2venetoclax 1treosulfan 1tislelizumab 1thymoglobulin 1ruxolitinib 1pevonedistat 1peginterferon alfa-2a 1nilotinib 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Sirolimus 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Immune Checkpoint Inhibitors 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Dasatinib 1Cord Blood Stem Cell Transplantation 1Clofarabine 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × Mycophenolic Acid × Myeloid × Clear all
NCT03192397 2026-04-14

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Roswell Park Cancer Institute

Phase 1/2 Active not recruiting
35 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡